Senators question Allergan CEO on tribe patent deal

A group of five senators said the deal was a "blatant attempt to further Allergan's market monopoly" on its $1.5 billion eye drug, Restasis.

Allergan does patent deal for Restasis with Native American tribe

Allergan deal with Mohawk tribe casts patent shadow

Allergan Patent Deal May Hurt Competition, Lawmakers Say - Bloomberg

How a Native American tribe came to own one of the world's most valuable patents

Selling Sovereignty: How Corporations Used Tribal Sovereign Immunity to Evade Regulation and Exploit Consumers - The Flaw

Pharma's contentious inter partes reviews come under Supreme Court scrutiny

A handful of Allergan's top shareholders want to bring back the old CEO as chairman

Speaker Bios Do Not Delete - Foundry Events

CONTROVERSIAL STRATEGY: SELLING PATENTS TO A NATIVE AMERICAN TRIBE

Allergan Gains Another Approval for Botox Amid Patent Controversy Over Restasis - Xtalks

Allergan does patent deal for Restasis with Native American tribe

Allergan Gains Another Approval for Botox Amid Patent Controversy Over Restasis - Xtalks

Patent transfer to Mohawk tribe intended to stop generic drugs

Pharma Giant Allergan Fears Embrace Of Sanders's Medicare For All Plan